The Europe Neuromonitoring Devices Market is expected to witness market growth of 6.9% CAGR during the forecast period (2022-2028).
The market for neuromonitoring devices is anticipated to grow due to an increase in the prevalence of neurological diseases such epilepsy, Parkinson's disease, and Alzheimer's disease across all ages of individuals, particularly in the geriatric population. The market for neuromonitoring devices is expected to be driven by an increase in brain injuries, neurodegenerative disorders, neurological disease incidence rates, and recent growth of brain monitoring in clinical research. Opportunities for market participants in neuromonitoring devices are anticipated to arise from increasing demand for non-invasive and non-destructive technology, growing clinical applications of neuromonitoring devices, and growing healthcare markets in emerging nations.
By sequentially dilating each psoas muscle as it passes into the disc space, neuromonitoring is carried out. The localizable EMG electrodes on the dilators can be used to deliver directional stimulation to pinpoint the location and angular orientation of the motor nerves concerning the dilators. A K-wire is then inserted into the disc space to lock the initial dilator's position once the C-arm has confirmed its placement in the lateral position. The goal is to land in roughly the middle of the disc space, anterior to the motor neurons of the lumbar plexus. The sequential dilators and retractor are then passed to rest flush with the disc space after the AP image has been obtained.
A strong healthcare system and an increase in non-invasive device certifications in the area are driving the demand for non-invasive technologies. New entrants and local players received CE mark authorization for their non-invasive devices throughout 2017-2018.
According to the European Academy of Neurology (EAN), there are approximately 307,859,199 neurological diseases present in European nations. They carry a high risk of adverse health outcomes, including hospitalization, institutionalization, institutional death, and disability. Degenerative illnesses like dementia and Parkinson's disease, strokes, migraines, and other neurological conditions are frequently present in older persons.
RCPsych portals went live on April 26, 2020, ABN portals went live on April 3, 2020, BASP portals on April 21, 2020, and ABN portals on April 2, 2020. The platforms were notified of 153 distinct cases that satisfied the clinical case criteria by doctors in the UK during this period, similar to the overall COVID-19 data from UK government public health organizations.
The Germany market dominated the Europe Neuromonitoring Devices Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $525.5 million by 2028. The UK market is experiencing a CAGR of 6% during (2022-2028). Additionally, The France market is expected to exhibit a CAGR of 7.7% during (2022-2028).
Based on Product, the market is segmented into Doppler Ultrasound, EEG, Fetal/Neonatal Neuro-Monitoring Devices, Intracranial Pressure Monitoring, Cerebral Ox meter, Near Infrared Spectroscopy, Speckle Imaging, Micro Ultrasound, and Others. Based on End User, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Medtronic PLC, Nihon Kohden Corporation, Natus Medical Incorporated, Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.
By Product
The market for neuromonitoring devices is anticipated to grow due to an increase in the prevalence of neurological diseases such epilepsy, Parkinson's disease, and Alzheimer's disease across all ages of individuals, particularly in the geriatric population. The market for neuromonitoring devices is expected to be driven by an increase in brain injuries, neurodegenerative disorders, neurological disease incidence rates, and recent growth of brain monitoring in clinical research. Opportunities for market participants in neuromonitoring devices are anticipated to arise from increasing demand for non-invasive and non-destructive technology, growing clinical applications of neuromonitoring devices, and growing healthcare markets in emerging nations.
By sequentially dilating each psoas muscle as it passes into the disc space, neuromonitoring is carried out. The localizable EMG electrodes on the dilators can be used to deliver directional stimulation to pinpoint the location and angular orientation of the motor nerves concerning the dilators. A K-wire is then inserted into the disc space to lock the initial dilator's position once the C-arm has confirmed its placement in the lateral position. The goal is to land in roughly the middle of the disc space, anterior to the motor neurons of the lumbar plexus. The sequential dilators and retractor are then passed to rest flush with the disc space after the AP image has been obtained.
A strong healthcare system and an increase in non-invasive device certifications in the area are driving the demand for non-invasive technologies. New entrants and local players received CE mark authorization for their non-invasive devices throughout 2017-2018.
According to the European Academy of Neurology (EAN), there are approximately 307,859,199 neurological diseases present in European nations. They carry a high risk of adverse health outcomes, including hospitalization, institutionalization, institutional death, and disability. Degenerative illnesses like dementia and Parkinson's disease, strokes, migraines, and other neurological conditions are frequently present in older persons.
RCPsych portals went live on April 26, 2020, ABN portals went live on April 3, 2020, BASP portals on April 21, 2020, and ABN portals on April 2, 2020. The platforms were notified of 153 distinct cases that satisfied the clinical case criteria by doctors in the UK during this period, similar to the overall COVID-19 data from UK government public health organizations.
The Germany market dominated the Europe Neuromonitoring Devices Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $525.5 million by 2028. The UK market is experiencing a CAGR of 6% during (2022-2028). Additionally, The France market is expected to exhibit a CAGR of 7.7% during (2022-2028).
Based on Product, the market is segmented into Doppler Ultrasound, EEG, Fetal/Neonatal Neuro-Monitoring Devices, Intracranial Pressure Monitoring, Cerebral Ox meter, Near Infrared Spectroscopy, Speckle Imaging, Micro Ultrasound, and Others. Based on End User, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Medtronic PLC, Nihon Kohden Corporation, Natus Medical Incorporated, Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Doppler Ultrasound
- EEG
- Fetal/Neonatal Neuro-Monitoring Devices
- Intracranial Pressure Monitoring
- Cerebral Oximeter
- Near Infrared Spectroscopy
- Speckle Imaging
- Micro Ultrasound
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Koninklijke Philips N.V.
- Medtronic PLC
- Nihon Kohden Corporation
- Natus Medical Incorporated
- Nuvasive, Inc.
- Advanced Brain Monitoring, Inc.
- Intranerve Neuroscience Holdings, Llc
- Specialtycare
- RIMED Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Europe Neuromonitoring Devices Market by Product
Chapter 5. Europe Neuromonitoring Devices Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Koninklijke Philips N.V.
- Medtronic PLC
- Nihon Kohden Corporation
- Natus Medical Incorporated
- Nuvasive, Inc.
- Advanced Brain Monitoring, Inc.
- Intranerve Neuroscience Holdings, Llc
- Specialtycare
- RIMED Ltd.
Methodology
LOADING...
